Treatment of Metastatic Breast Cancer with AZQ: A Phase II Trial

Silvana Martino Division of Medical Oncology, Wayne State University, and Harper-Grace Hospitals, Detroit, Michigan

Vorachai Ratanatharathom Division of Medical Oncology, Wayne State University, and Harper-Grace Hospitals, Detroit, Michigan

Bohumil A. Samal Division of Medical Oncology, Wayne State University, and Harper-Grace Hospitals, Detroit, Michigan

Amnuay Singhakowinta Division of Medical Oncology, Wayne State University, and Harper-Grace Hospitals, Detroit, Michigan

Charles Haas Division of Medical Oncology, Wayne State University, and Harper-Grace Hospitals, Detroit, Michigan

References

Driscoll J S., Dubeclc L, Congleton G, Geran R I. Potential CNS antitumor agents. J Pharmacol Set 1979; 68(2)185–188
PubMed Web of Science ®Google Scholar
Goldin A, Venditti J M. Progress report on the screening program at the Division of Cancer Treatment, National Cancer Institute. Cancer Treat Rev 1980; 7: 167–176
PubMed Web of Science ®Google Scholar
Schilcher R B., Young J D., Leichman L P., et al. Phase I evaluation and pharmacokinetics of aziridiny lbenzoquinone using a weekly intravenous schedule. Cancer Res 1983; 43: 3907–3911
PubMed Web of Science ®Google Scholar
Budman D R., Forastiere A, Perloff M, et al. Aziridinylbenzoqui-none (AZQ) in advanced breast cancer: A Cancer and Leukemia Group B phase H trial. Cancer Treat Rep 1982; 66(10)1875–1876
PubMedGoogle Scholar
Yap H Y., Bedikian A Y., Schell F C., et al. Phase II clinical evaluation of AZQ in metastatic breast cancer. Am J Clin Oncol 1983; 6: 31–33
PubMed Web of Science ®Google Scholar
Wittes R E., Marsoni S, Simon R, Leyland-Jones B. The Phase n trial. Cancer Treat Rep 1985; 69(11)1235–1239
PubMedGoogle Scholar
Martino S, Samal B A., Vaitkevicius V K., et al. 4′Deoxydoxorubicin (DxDx) as first line therapy for metastatic breast cancer (abstr. 30). Breast Cancer Res Treat 1985; 6(2)171
Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Treatment of Metastatic Breast Cancer with AZQ: A Phase II Trial

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Treatment of Metastatic Breast Cancer with AZQ: A Phase II Trial

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date